China Pharma Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for China Pharma Holdings, Inc. (CPHI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.631.422.034.860.96
Cash & Short-Term Investments0.631.422.034.860.96
Accounts Receivable0.260.500.420.71-0.47
Inventory2.283.732.953.343.71
Other Current Assets0.080.110.080.060.00
Total Current Assets3.276.005.969.095.32
Non-Current Assets
Property, Plant & Equipment (Net)4.926.829.6112.9715.61
Intangible Assets6.703.652.210.590.18
Other Non-Current Assets0.000.000.010.000.05
Total Non-Current Assets11.6210.4711.8213.5615.85
Total Assets14.8916.4717.7822.6521.12
Current Liabilities
Accounts Payable0.230.970.670.934.16
Short-Term Debt1.023.108.727.112.04
Current Portion of Long-Term Debt1.021.976.244.332.04
Accrued Liabilities2.430.300.400.302.63
Deferred Revenue0.160.090.520.210.72
Other Current Liabilities1.830.000.370.332.13
Total Current Liabilities5.026.8212.7410.5111.40
Non-Current Liabilities
Long-Term Debt1.391.410.005.250.90
Deferred Tax Liabilities0.730.740.750.820.81
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities2.122.190.756.121.71
Total Liabilities7.149.0113.4916.6313.11
Stockholders' Equity
Common Stock0.030.010.000.050.05
Retained Earnings-44.03-39.29-36.21-32.24-16.49
Accumulated Other Comprehensive Income11.1411.4511.5712.5612.35
Additional Paid-in Capital40.6035.2828.9325.6524.45
Shares Outstanding3.261.060.150.090.00
Total Stockholders' Equity7.757.454.296.028.00
Total Liabilities & Equity14.8916.4717.7822.6521.12